تجاوز إلى المحتوى الرئيسي
drug protocol number
232SM203
drug sponsor
Biogen Idec Research Limited
drug study
Nusinersen (Spinraza)
drug trial site
King Fahad Specialist Hospital (Dammam)
drug status
Ongoing
drug phase